CAMOSTAT

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H22N4O5
Molecular Weight	398.4125
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of CAMOSTAT

Structure Search

SMILES

CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1

InChI

InChIKey=XASIMHXSUQUHLV-UHFFFAOYSA-N

InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)

HIDE SMILES / InChI

Molecular Formula	C20H22N4O5
Molecular Weight	398.4125
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:42:12 UTC 2023` Edited by `admin` on `Fri Dec 15 15:42:12 UTC 2023`
Record UNII	0FD207WKDU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CAMOSTAT

Official Name

English

camostat [INN]

Common Name

English

CAMOSTAT [MI]

Common Name

English

Camostat [WHO-DD]

Common Name

English

P-GUANIDINOBENZOIC ACID, ESTER WITH (P-HYDROXYPHENYL)ACETIC ACID, ESTER WITH N,N-DIMETHYLGLYCOLAMIDE

Common Name

English

Classification Tree Code System Code

WHO-VATC

QB02AB04

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

WHO-ATC

B02AB04

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

NCI_THESAURUS

C783

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

FDA ORPHAN DRUG

338211

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

Code System Code Type Description

MESH

C034532

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

MERCK INDEX

m3000

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

Merck Index

EPA CompTox

DTXSID6044010

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

DRUG CENTRAL

471

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

CHEBI

135632

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

CAS

59721-28-7

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

DRUG BANK

DB13729

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

ChEMBL

CHEMBL590799

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

PUBCHEM

2536

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

NCI_THESAURUS

C73213

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

FDA UNII

0FD207WKDU

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

SMS_ID

100000081618

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

EVMPD

SUB06066MIG

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

INN

5068

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

WIKIPEDIA

CAMOSTAT

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

IUPHAR

6432

Created by admin on Fri Dec 15 15:42:12 UTC 2023 , Edited by admin on Fri Dec 15 15:42:12 UTC 2023

PRIMARY

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->INHIBITOR

Comments:

In vitro study showed that Camostat reduces significantly the infection of Calu-3 lung cells by SARS-CoV-2, the virus responsible for COVID-19.

Amount:


					XJ447D496R

TRANSMEMBRANE PROTEASE SERINE 2

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					451M50A1EQ

CAMOSTAT MESYLATE

SALT/SOLVATE -> PARENT

Amount:

Related Record Type Details


					487JA5G388

FOY-251

METABOLITE ACTIVE -> PARENT

Interaction Type:

MAJOR

Amount:

Related Record Type Details


					0FD207WKDU

CAMOSTAT

ACTIVE MOIETY

Amount: